April 25, 2025
1 min watch
Save
VIDEO: Nordic, Harrow launch generic Maxitrol
LOS ANGELES — Nordic Pharma and Harrow partnered to launch an authorized generic of Maxitrol, Nordic President Philip Gioia said in this Healio Video Perspective from SightLine.
Gioia said the neomycin and polymyxin B sulfates and dexamethasone ophthalmic suspension will offer a more cost-effective generic option for patients in need of an anti-infective and anti-inflammatory treatment.
Reference:
- Nordic Group B.V. through its subsidiary Nordic Pharma Inc. announces launch of authorized generic of Maxitrol (neomycin and polymyxin B sulfates and dexamethasone ophthalmic suspension). https://www.prnewswire.com/news-releases/nordic-group-bv-through-its-subsidiary-nordic-pharma-inc-us-announces-launch-of-authorized-generic-of-maxitrol-neomycin-and-polymyxin-b-sulfates-and-dexamethasone-ophthalmic-suspension-302436485.html?tc=eml_cleartime. Posted April 24, 2025. Accessed April 25, 2025.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Gioia reports being president of Nordic Pharma.
Read more about